Antonio Volpi

Qualifica
ASSOCIATO CONFERMATO
Fonte dei dati: Archivio della Ricerca http://art.torvergata.it
  1. Benvenuto, M., Mattera, R., Sticca, J.i., Rossi, P., Cipriani, C., Giganti, M.g., et al. (2018). Effect of the BH3 mimetic polyphenol (-)-Gossypol (AT-101) on the in vitro and in vivo growth of malignant mesothelioma. FRONTIERS IN PHARMACOLOGY, 9(1269). Dettagli
  2. Pica, F., Ciotti, M., Maurici, M., Buè, C., Nardi, P., Lucà, G., et al. (2017). Clinical features and outcome of hospitalized patients with HSV-1 DNA in the lower respiratory tract. NEW MICROBIOLOGICA, 40(2), 107-112. Dettagli
  3. Gabutti, G., Bonanni, P., Conversano, M., Fanelli, G., Franco, E., Greco, D., et al. (2017). Prevention of Herpes Zoster and its complications: From clinical evidence to real life experience. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 13(2), 391-398. Dettagli
  4. Torcel-Pagnon, L., Bricout, H., Bertrand, I., Perinetti, E., Franco, E., Gabutti, G., et al. (2016). Impact of Underlying Conditions on Zoster-Related Pain and on Quality of Life Following Zoster. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 72(8), 1091-1097. Dettagli
  5. Pica, F., Chimenti, M.s., Gaziano, R., Buè, C., Casalinuovo, I.a., Triggianese, P., et al. (2016). Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 186(1), 39-45. Dettagli
  6. Lal, H., Cunningham, A.L., Godeaux, O., Chlibek, R., Diez-Domingo, J., Hwang, S.J., et al. (2015). Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. NEW ENGLAND JOURNAL OF MEDICINE, 372(22), 2087-2096. Dettagli
  7. Maggi, S., Gabutti, G., Franco, E., Bonanni, P., Ferro, A., Lazzari, M., et al. (2015). Preventing and managing herpes zoster: key actions to foster healthy aging. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 27(1), 5-11. Dettagli
  8. Gabutti, G., Franco, E., Bonanni, P., Conversano, M., Ferro, A., Lazzari, M., et al. (2015). Reducing the burden of Herpes Zoster in Italy. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 11, 101-107. Dettagli
  9. Capozzi, C., Fontana, C., Volpi, A., Lombardi, G., Lisena, F., Paulon, L., et al. (2015). HEALTHCARE ASSOCIATED INFECTIONSImpact of Diagnosis and Management of Clostridium Difficile Infections (CDI)The Experience of a University Hospital in Rome. Paper presented at Congresso Europeo ISPOR, Milano. Dettagli
  10. Capozzi, C., Volpi, A., Maurici, M., Visconti, G., & Panà, A. (2015). Malattia da Virus Ebola (MVE): proposta di linea guida per il triage ospedaliero dei casi sospetti e probabili. IGIENE E SANITÀ PUBBLICA, 71(1), 89-113. Dettagli
  11. Capozzi, C., Volpi, A., Maurici, M., Visconti, G., & Panà, A. (2015). [Ebola Virus Disease (EVD): proposed guideline for hospital triage of suspect and probable cases]. IGIENE E SANITÀ PUBBLICA, 71(1), 89-113. Dettagli
  12. De Kreutzenberg, S.v., Fadini, G.p., Guzzinati, S., Mazzucato, M., Volpi, A., Coracina, A., et al. (2015). Carotid plaque calcification predicts future cardiovascular events in type 2 diabetes. DIABETES CARE, 38(10), 1937-1944. Dettagli
  13. Bricout, H., Perinetti, E., Marchettini, P., Ragni, P., Zotti, C., Gabutti, G., et al. (2014). Burden of herpes zoster-associated chronic pain in Italian patients aged 50 years and over (2009¿2010): a GP-based prospective cohort study. BMC INFECTIOUS DISEASES, 14(1), 637-648. Dettagli
  14. Pica, F., Gatti, A., Divizia, M., Lazzari, M., Ciotti, M., Sabato, A., et al. (2014). One-year follow-up of patients with long-lasting post-herpetic neuralgia. BMC INFECTIOUS DISEASES, 14, 556-564. Dettagli
  15. Franco, E., Gabutti, G., Bonanni, P., Conversano, M., Valente, S., Ferro, A., et al. (2014). Herpes Zoster and its prevention in Italy. Scientific consensus statement. IGIENE E SANITÀ PUBBLICA, 70(1), 111-127. Dettagli
  16. Gabutti, G., Franco, E., Bonanni, P., Conversano, M., Ferro, A., Lazzari, M., et al. (2014). Reducing the burden of Herpes Zoster in Italy. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 11(1). Dettagli
  17. Capozzi C, Volpi A, Maurici M, Lisena FP, Visconti G, & Panà A. (2013). Healthcare-associated infections and antibiotic resistance: a global challenge for the 21st century. IGIENE E SANITÀ PUBBLICA, 69(5), 657-691. Dettagli
  18. Griffiths, S.J., Koegl, M., Boutell, C., Zenner, H.L., Crump, C.M., Pica, F., et al. (2013). A Systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replication. PLOS PATHOGENS. Dettagli
  19. Volpi, A., & Pica, F. (2013). Epstein-Barr virus and CNS infectionjs. In S.K. Singh, & D. Ruzek (a cura di), Neuroviral infections. CRC press. Dettagli
  20. Pica, F., & Volpi, A. (2012). Public awareness and knowledge of herpes labialis. JOURNAL OF MEDICAL VIROLOGY, 84(1), 132-137. Dettagli
  21. Nicastri, E., Dori, L., Buonomini, A.R., Tommasi, C., De Nardo, P., Bellagamba, R., et al. (2012). HIV neutralizing antibody titer during structured treatment interruption of highly active antiretroviral therapy. AIDS, 26(11), 1451-1452. Dettagli
  22. Vernole, P., Muzi, A., Dorio, A.L., Tentori, L., Volpi, A., & Graziani, G. (2012). DNA damaging agents can induce celll cycle arrest in different phases of mitosis. In Program and abstracts of the 12th FISV Congress : University of Rome La Sapienza, September 24-27, 2012 (pp.44-44). FISV. Dettagli
  23. Volpi, A., Gatti, A., & Pica, F. (2011). Frequency of herpes zoster recurrence. Mayo Clinic proceedings. Mayo Clinic, 86(6), 586-587. Dettagli
  24. Vernole, P., Muzi, A., Volpi, A., Terrinoni, A., Dorio, A.S., Tentori, L., et al. (2011). Common fragile sites in colon cancer cell lines: role of mismatch repair, RAD51 and poly(ADP-ribose) polymerase-1. MUTATION RESEARCH, 712(1-2), 40-48. Dettagli
  25. Vernole, P., Muzi, A., Dorio, A.S., Tentori, L., Volpi, A., & Graziani, G. (2011). Differential effects on mitosis of DNA damaging agents with distinct mechanisms. Paper presented at W.Bernhard workshop, Riga (Lettonia). Dettagli
  26. Vernole, P., Muzi, A., Volpi, A., Tentori, L., & Graziani, G. (2011). Role of DNA repair pathways in the control of common fragile sites expression.. Paper presented at 24 congresso annuale dell’AICC,, Roma. Dettagli
  27. Whitley, R.J., Volpi, A., McKendrick, M., Wijck, A.v., & Oaklander, A.L. (2010). Management of herpes zoster and post-herpetic neuralgia now and in the future. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 48 Suppl 1, S20-8. Dettagli
  28. Emberti, L., Gialloreti, L.E., Merito, M., Pezzotti, P., Naldi, L., Gatti, A., et al. (2010). Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. BMC INFECTIOUS DISEASES, 230. Dettagli
  29. Gatti, A., Pica, F., Boccia, M.t., De Antoni, F., Sabato, A.F., & Volpi, A. (2010). No evidence of family history as a risk factor for herpes zoster in patients with post-herpetic neuralgia. JOURNAL OF MEDICAL VIROLOGY, 82(6), 1007-1011. Dettagli
  30. Parruti, G., Tontodonati, M., Rebuzzi, C., Polilli, E., Sozio, F., Consorte, A., et al. (2010). Predictors of pain intensity and persistence in a prospective Italian cohort of patients with herpes zoster: relevance of smoking, trauma and antiviral therapy. BMC MEDICINE, 8, 58. Dettagli
  31. Pica, F., Volpi, A., Gaziano, R., & Garaci, E. (2010). Interferon-lambda in immunocompetent individuals with a history of recurrent herpes labialis. ANTIVIRAL THERAPY, 15(5), 737-743. Dettagli
  32. Vernole, P., Muzi, A., Volpi, A., Terrinoni, A., Tentori, L., Shah, G., et al. (2010). Homologous recombination but not poly(adp-ribose) polymerase-1 is involved in the control of common fragile sites stability. Paper presented at Instabilità genetica e riparazione del DNA: nuovi paradigmi per la ricerca translazionale, Roma. Dettagli
  33. P. Vernole, A.M. (2009). DNA repair defects and chromosomal fragile sites expression.. Paper presented at ICEM-10th International Conference on Environmental Mutagens, Firenze, Italia. Dettagli
  34. Sarmati L., A.C. (2009). Prognostic factors of long-term CD4+ count-guided interruption of antiretroviral treatment. JOURNAL OF MEDICAL VIROLOGY, 81(3), 481-487. Dettagli
  35. Vernole, P., Muzi, A., Volpi, A., Dorio, A.S., Terrinoni, A., Shah, G.M., et al. (2009). Inhibition of homologous recombination by treatment with BVDU (brivudin) or by RAD51 silencing increases chromosomal damage induced by bleomycin in mismatch repair-deficient tumour cells. MUTATION RESEARCH, 664, 39-47. Dettagli
  36. Volpi, A., Sarrecchia, C., & Sordillo, P. (2009). Aciclovir, herpes viruses and HIV: a never-ending story. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 7(4), 403-407. Dettagli
  37. Volpi, A., Gatti, A., Pica, F., Bellino, S., Marsella, L.T., & Sabato, A.F. (2008). Clinical and psychosocial correlates of post-herpetic neuralgia. JOURNAL OF MEDICAL VIROLOGY, 80(9), 1646-1652. Dettagli
  38. Vernole, P., Muzi, A., Graziani, G., & Volpi, A. (2008). 5(2-bromovinyl)-2’-deoxyuridine (BVDU), increases the amount of chromatid breaks induced by bleomycin in mismatch repair deficient tumor cells by inhibiting homologous recombination. Paper presented at ELSO Meeting ,, Nizza,Francia. Dettagli
  39. Volpi, A. (2007). Severe complications of herpes zoster. HERPES, 14 Suppl 2, 35-39. Dettagli
  40. Volpi, A., Gatti, A., Serafini, G., Costa, B., Suligoi, B., Pica, F., et al. (2007). Clinical and psychosocial correlates of acute pain in herpes zoster. JOURNAL OF CLINICAL VIROLOGY, 38(4), 275-279. Dettagli
  41. Pica, F., & Volpi, A. (2007). Transmission of human herpesvirus 8: An update. CURRENT OPINION IN INFECTIOUS DISEASES, 20(2), 152-156. Dettagli
  42. Pica, F., Serafino, A., Divizia, M., Donia, D., Fraschetti, M., Sinibaldi-Salimei, P., et al. (2006). Effect of extremely low frequency electromagnetic fields (ELF-EMF) on Kaposi's sarcoma-associated herpes virus in BCBL-1 cells. BIOELECTROMAGNETICS, 27(3), 226-232. Dettagli
  43. Pica, F., Serafino, A., Divizia, M., Donia, D., Fraschettl, M., Sinibaldi-Salimei, P., et al. (2006). Effect of extremely low frequency electromagnetic fields (ELF-EMF) on Kaposi's sarcoma-associated Herpes virus in BCBL-1 cells. BIOELECTROMAGNETICS, 27(3), 226-232. Dettagli
  44. VOLPI A, P.F. (2006). La gestione del paziente con Herpes zoster. p. 10-15, ISSN: 0390-0347. MEDICO E PAZIENTE. Dettagli
  45. Gialloreti, L., Divizia, M., Pica, F., & Volpi, A. (2005). Analysis of the cost-effectiveness of varicella vaccine programmes based on an observational survey in the Latium region of Italy. HERPES, 12(2), 33-37. Dettagli
  46. Gentile, G., Capobianchi, A., Volpi, A., Palù, G., Pica, F., Calistri, A., et al. (2005). Human herpesvirus 8 DNA in serum during seroconversion in allogeneic bone marrow transplant recipients. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 97(13), 1008-1011. Dettagli
  47. Volpi, A., Gross, G., Hercogova, J., & Johnson, R.W. (2005). Current management of herpes zoster: The European view. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 6(5), 317-325. Dettagli
  48. Volpi, A., Sarmati, L., Suligoi, B., Montano, M., Rezza, G., & Andreoni, M. (2004). Correlates of human herpes virus-8 and herpes simplex virus type 2 infections in Northern Cameroon. JOURNAL OF MEDICAL VIROLOGY, 74(3), 467-472. Dettagli
  49. PICA F, V.A. (2004). Herpes genitale in gravidanza. vol. 23, p. 2-4. STD NEWS,. Dettagli
  50. Pica, F., Serafino, A., Garaci, E., & Volpi, A. (2004). Cidofovir on HHV-8 in BCBL-1 cells. ANTIVIRAL THERAPY, 9(5), 823-825. Dettagli
  51. Volpi, A., Gentile, G., Pica, F., & Suligoi, B. (2002). Antiviral treatment of varicella in pediatric practice in the Latium region of Italy: results of an observational study. THE PEDIATRIC INFECTIOUS DISEASE JOURNAL, 21(8), 739-743. Dettagli
  52. Barillari, G., Albonici, L., Incerpi, S., Bogetto, L., Pistritto, G., Volpi, A., et al. (2001). Inflammatory cytokines stimulate vascular smooth muscle cells locomotion and growth by enhancing alpha5beta1 integrin expression and function. ATHEROSCLEROSIS, 154(2), 377-385. Dettagli
  53. Pica, F., Volpi, A., Serafino, A., Fraschetti, M., & Garaci, E. (2000). Studio sulla relazione esistente tra Nerve growth factor (NGF), infezione da Herpesvirus umano 8 (HHV-8 o KSHV) e patologie HHV-8-correlate. S.I.M.M.O.C- .8° convegno.Roma 22-23 Giugno- GIMMOC, IV-C&M1, 5-5. Dettagli
  54. Pica, F., Volpi, A., Serafino, A., Fraschetti, M., Franzese, O., & Garaci, E. (2000). Role of NGF on cell survival and virus maturation in HHV-8-infected primary effusion lymphoma cells. ISTISAN CONGRESSI, 36, 299-299. Dettagli
  55. VOLPI, A., & PICA, F. (2000). Virus dell’Herpes Simplex. MICROBIOLOGIA MEDICA, 15(1), 57-65. Dettagli
  56. VOLPI, A., PICA, F., GENTILE, G., CAPOBIANCHI, A., FRASCHETTI, M., & MARTINO, P. (1999). Neutralizing antibody response against human cytomegalovirus in allogeneic bone marrow-transplant recipients. THE JOURNAL OF INFECTIOUS DISEASES, 180(5), 1747-1748. Dettagli
  57. Volpi, A., Pica, F., Gentile, G., Capobianchi, A., Fraschetti, M., & Martino, P. (1999). Neutralizing antibody response against human cytomegalovirus in allogeneic bone marrow-transplant recipients. THE JOURNAL OF INFECTIOUS DISEASES, 180(5), 1747-1748. Dettagli
  58. Volpi A, P.F. (1999). Direct diagnosis of HSV Infections. vol. 5, p. 31-32. HERPES. Dettagli
  59. Fraschetti, M., Pica, F., & Volpi, A. (1997). Anticorpi per HHV8 in pazienti con infezione da HIV. GIORNALE ITALIANO DI MALATTIE INFETTIVE, 3, suppl.1. Dettagli
  60. Volpi, A., Pica, F., Cauletti, M., Panà, A., & Rocchi, G. (1988). Cytomegalovirus infection in day care centers in Rome, Italy: viral excretion in children and occupational risk among workers. JOURNAL OF MEDICAL VIROLOGY, 26(2), 119-125. Dettagli
  61. AUSILI G, G.D. (1987). Prevalenza di marcatori sierologici dell'infezione da rosolia e da citomegalovirus nel personale femminile degli asili nido. vol. 3, p. 63-65. PROGETTO SALUTE. Dettagli
  62. PICA F, V.A. (1987). Cistite emorragica da Adenovirus in un paziente sottoposto a trapianto di midollo osseo. vol. 39, p. 977-978. GIORNALE DI MALATTIE INFETTIVE E PARASSITARIE. Dettagli
  63. Andreoni M, R.L. (1985). Indagini sull'infezione da virus Herpes simplex in casi di vaginite aspecifica in gravidanza. vol. 37, p. 1009-1010. GIORNALE DI MALATTIE INFETTIVE E PARASSITARIE. Dettagli
  64. PICA F, V.A. (1985). L'infezione da Citomegalovirus (CMV) in patologia umana. , vol. Numero 0 - Anno 1, p. 38-41. SALUTE 2000. Dettagli
  65. Pica F, T.R. (1985). Un caso di riattivazione contemporanea della infezione da virus Herpes Simplex 1 e 2 in seguito a trapianto di rene. vol. 37, p. 983-984. GIORNALE DI MALATTIE INFETTIVE E PARASSITARIE. Dettagli
  66. VOLPI A, S.L. (1985). Infezione da Citomegalovirus di cellule linfomonocitarie. vol. 37, p. 1012-1013. GIORNALE DI MALATTIE INFETTIVE E PARASSITARIE. Dettagli
  67. VOLPI A, V.G. (1985). Indagini sulla reattività anticorpale per Citomegalovirus nel morbo di Sjogren. vol. 37, p. 1014-1015. GIORNALE DI MALATTIE INFETTIVE E PARASSITARIE. Dettagli
  68. Volpi, A., Cauletti, M., Gabrieli, R., Murri, G., Pica, F., Spadea, A., et al. (1984). Indagine preliminare sulla storia naturale dell'infezione da Citomegalovirus nell'infanzia. IGIENE E SANITÀ PUBBLICA, 40, 239-243. Dettagli